Coeptis Therapeutics Holdings Inc
COEP11.270USD
+0.660+6.22%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
58.13M시가총액
손실P/E TTM
자세한 내용은 Coeptis Therapeutics Holdings Inc 회사
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company. The Company is focused on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed by the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and robotic process automation capabilities. The Company’s subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Coeptis Therapeutics Holdings Inc 정보
종목 코드 COEP
회사 이름Coeptis Therapeutics Holdings Inc
상장일Dec 17, 2020
CEOMehalick (David)
직원 수5
유형Ordinary Share
회계 연도 종료Dec 17
주소105 Bradford Road, Suite 420
도시WEXFORD
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호15090
전화17249346467
웹사이트https://coeptistx.com/
종목 코드 COEP
상장일Dec 17, 2020
CEOMehalick (David)
Coeptis Therapeutics Holdings Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. David Mehalick
Mr. David Mehalick
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
130.07K
--
Ms. Christine Sheehy
Ms. Christine Sheehy
Vice President - Compliance, Secretary
Vice President - Compliance, Secretary
50.53K
--
Mr. Daniel (Dan) Yerace
Mr. Daniel (Dan) Yerace
Vice President - Operations, Director
Vice President - Operations, Director
45.53K
--
Mr. Christopher Calise
Mr. Christopher Calise
Independent Director
Independent Director
--
--
Mr. Brian Cogley
Mr. Brian Cogley
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Tara Maria Desilva, Ph.D.
Dr. Tara Maria Desilva, Ph.D.
Independent Director
Independent Director
--
--
Mr. Philippe Deschamps
Mr. Philippe Deschamps
Independent Director
Independent Director
--
--
Mr. Christopher Cochran
Mr. Christopher Cochran
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. David Mehalick
Mr. David Mehalick
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
130.07K
--
Ms. Christine Sheehy
Ms. Christine Sheehy
Vice President - Compliance, Secretary
Vice President - Compliance, Secretary
50.53K
--
Mr. Daniel (Dan) Yerace
Mr. Daniel (Dan) Yerace
Vice President - Operations, Director
Vice President - Operations, Director
45.53K
--
Mr. Christopher Calise
Mr. Christopher Calise
Independent Director
Independent Director
--
--
Mr. Brian Cogley
Mr. Brian Cogley
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Tara Maria Desilva, Ph.D.
Dr. Tara Maria Desilva, Ph.D.
Independent Director
Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Thu, Nov 20
마지막 업데이트: Thu, Nov 20
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
5.89%
Calise (Chris)
5.43%
Mehalick (David)
2.26%
Armistice Capital LLC
1.64%
Sheehy (Christine Elise)
0.88%
기타
83.90%
주주
주주
비율
The Vanguard Group, Inc.
5.89%
Calise (Chris)
5.43%
Mehalick (David)
2.26%
Armistice Capital LLC
1.64%
Sheehy (Christine Elise)
0.88%
기타
83.90%
주주 유형
주주
비율
Individual Investor
9.42%
Investment Advisor
6.11%
Hedge Fund
1.97%
Investment Advisor/Hedge Fund
1.13%
기타
81.37%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
36
241.64K
3.38%
--
2025Q3
37
241.64K
3.76%
+42.71K
2025Q2
35
198.94K
3.83%
+46.67K
2025Q1
35
152.27K
2.68%
+61.98K
2024Q4
37
107.84K
11.51%
-74.49K
2024Q3
50
182.34K
16.17%
+98.47K
2024Q2
52
83.87K
26.32%
-153.34K
2024Q1
74
237.20K
33.65%
-370.03K
2023Q4
75
236.65K
31.22%
+72.09K
2023Q3
78
164.55K
39.28%
-2.06K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
50.67K
0.89%
+23.15K
+84.08%
Sep 30, 2025
Calise (Chris)
312.69K
5.5%
--
--
Dec 18, 2025
Mehalick (David)
130.07K
2.29%
--
--
Dec 18, 2025
Armistice Capital LLC
94.77K
1.67%
+94.77K
--
Sep 30, 2024
Sheehy (Christine Elise)
50.53K
0.89%
--
--
Dec 18, 2025
Yerace (Daniel Alexander)
45.53K
0.8%
--
--
Dec 18, 2025
Geode Capital Management, L.L.C.
37.38K
0.66%
+17.10K
+84.30%
Sep 30, 2025
State Street Investment Management (US)
19.87K
0.35%
+19.87K
--
Sep 30, 2025
Renaissance Technologies LLC
18.50K
0.33%
+18.50K
--
Sep 30, 2025
Yorkville Advisors Global, LP.
8.00K
0.14%
-44.72K
-84.83%
Sep 30, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
날짜
배당락일
유형
비율
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
